Rallybio Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.75

+0.10 (+2.12%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 6 60%

Hold 4 40%

Sell 0 0%

Price Target

Analyst Price Target +191.2% upside

Low Target $9.36

Average Target $13.83

High Target $17.78

Current Price $4.75

Current
$4.75

Target
$13.83

$9.36 $13.83 avg $17.78

Scenario Analysis

Bear Case

$9.36

97.1%

Low target

Base Case

$13.83

+191.2%

Avg target

Bull Case

$17.78

+274.3%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$15.22

-68.8% from high

52-Week Low

$8.80

+-46.0% from low

Target vs 52W High

$13.83

-9.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%